The tell-tale heart – Health Investor

The tell-tale heart – Health Investor

In a wide-ranging interview featured in the latest edition of HealthInvestor (February 2019), our chairman Robert Barr discusses Creavo’s MCG device Corsens, and shares our ambitious plans for commercialisation and the potential for further device applications. Robert...
Creavo to attend DiTA launch event

Creavo to attend DiTA launch event

We are pleased to announce that we will be attending the DiTA launch event in Manchester next week. DiTA (the Diagnostics and Technology Accelerator) is a new initiative by the Manchester University NHS Foundation Trust that will work with in-vitro diagnostics and...
Creavo to attend Arab Health

Creavo to attend Arab Health

We are delighted to announce that next week, Creavo will be attending the Arab Health conference in Dubai (28 – 31 January 2019) You will be able to find us on stand S1 K30 hosted by our UAE distributors, Atlas Medical. We will be discussing how innovative...
An incredible year for Creavo with exciting prospects for 2019

An incredible year for Creavo with exciting prospects for 2019

By Steve Parker, Chief Executive Officer It’s been an incredible year for Creavo, as we move ever closer to the commercialisation of Corsens®, the world’s first deployable MCG device with the potential to revolutionise the cardiac triage process, it is more important...
Creavo to attend MEDICA

Creavo to attend MEDICA

Creavo will be attending MEDICA in Düsseldorf this week. We will be showcasing our device Corsens to a range of potential partners, in hall 9, stand C42.  Corsens has the potential to completely transform the triage process in busy Emergency Departments globally as an...